Skip to main content
Equibles

CSS LLC/IL

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 1103646 CHICAGO, IL
Back to BMRN Full portfolio

Position in BMRN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,292,027
+$389,317 QoQ
Shares Held
22,580
+41.3% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#251
of 565 holders
Holding Since
Sep 2020
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BMRN Over Time

Shares Held

Position Value (USD)

Derivatives in BMRN

reported options exposure · as of Dec 31, 2020
CallValue
$455,988
CallShares
5,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CSS LLC/IL holds $23,787,576 across 16 Biotechnology names. BMRN ranks #3 (5.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 152,289 $12,074,994
2 JAZZ
Jazz Pharmaceuticals plc
 29,041 $6,998,009
3 BMRN
Biomarin Pharmaceutical Inc
This page 		22,580 $1,292,027
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,820 $1,134,842
5 HALO
Halozyme Therapeutics, Inc.
 6,520 $510,320
6 TVTX
Travere Therapeutics, Inc.
 8,470 $481,180
7 EXEL
Exelixis, Inc.
 8,709 $473,856
8 INCY
Incyte Corp
 3,856 $437,116

All Filings in BMRN

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,292,027 22,580
2026-03-31 $902,710 15,980
2025-12-31 $1,258,727 21,180
2025-09-30 $1,297,673 23,960
2025-06-30 $621,710 11,310
2024-03-31 $314,424 3,600
2023-12-31 $347,112 3,600
2023-09-30 $318,528 3,600
2020-12-31 $455,988 5,200
2020-09-30 $395,616 5,200